Clinical Trial

Dexmedetomidine vs Lignocaine for Reducing Intubation-Induced Hemodynamic Responses in Cardiac Surgery: A Randomized Controlled Trial

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
After confirming eligibility, written informed consent will be obtained by a trained team member who is not involved in assigning treatment or giving the study medication. Each participant will receive a unique study number to protect privacy. Participants will be randomly assigned to receive one of the study medications using a chance-based method.The study medication will be administered through a vein before placement of the breathing tube. Blood pressure and pulse rate will be measured before the procedure and at several time points after the breathing tube is inserted.
Trial Details
NCT Number NCT07611890
Lead Sponsor Rawalpindi Institute of Cardiology
Conditions Laryngoscopic Stress Response, Dexmedetomidine, Lignocaine
Enrollment 70 participants
Start Date 2026-05-21
Primary Completion 2026-08-21 (estimated)
Study Completion 2026-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-05-28